Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,529,379 papers from all fields of science
Search
Sign In
Create Free Account
D2E7 Antibody
Known as:
Antibody, D2E7
, D2E7
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
adalimumab
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
TLR 4 / NF-κB axis signaling pathway-dependent up-regulation of miR-625-5 p contributes to human intervertebral disc degeneration by targeting COL 1 A 1
Liqi Shen
,
Yun Xiao
,
Qishun Wu
,
Ling Liu
,
Caiguo Zhang
,
XueKun Pan
2019
Corpus ID: 149447232
The activation of the toll-like receptor 4 (TLR4)/nuclear factor-kappa B (NF-κB) signaling pathway has been found to play a…
Expand
2007
2007
METHODS AND COMPOSITIONS FOR DIAGNOSING ANKYLOSING SPONDYLITIS USING BIOMARKERS RELATED APPLICATIONS
2007
Corpus ID: 59362894
. Accordingly, methods of the invention can be used to provide improved treatment for AS by providing a method for determining…
Expand
2005
2005
TNF-α inhibitors
Z. Tutuncu
,
A. Kavanaugh
2005
Corpus ID: 68723243
The development of anti-TNF-α therapy has resulted in the potential to radically alter the course of inflammatory diseasessuch as…
Expand
2005
2005
Utilisation d'anticorps monoclonal anti tnf-alpha, d2e7, pour le traitement de troubles inflammatoires associes au tnf-alpha
Rebecca S. Hoffman
,
Elliot K. Chartash
,
Lori K. Taylor
,
G. R. Granneman
,
Philip Yan
2005
Corpus ID: 57123557
2004
2004
A fully human anti-TNF mAb adalimumab (D2E7) induces caspase-dependent apoptosis of human peripheral blood monocyte and T cells
Chong Shen
,
P. Maerten
,
G. Assche
,
K. Geboes
,
P. Rutgeerts
,
J. Ceuppens
2004
Corpus ID: 79291437
2002
2002
Een open-label multicenter studie ter bepaling van de veiligheid en effectiviteit van het volledig menselijke anti-TNF-alfa monoklonaal antilichaam adalimumab (D2E7) als aanvulling op een…
I. Speyer
,
M. L. Westedt
2002
Corpus ID: 151445682
2001
2001
OP0083 Long-term use of the fully human anti-tnf antibody adalimumab (d2e7) in dmard-refractory rheumatoid arthritis
F. Breedveld
,
C. Allaart
,
+10 authors
H. Kupper
2001
Corpus ID: 80113560
Background Objectives To evaluate the long-term efficacy and safety of the fully human anti-TNF antibody adalimumab (D2E7) given…
Expand
Review
2001
Review
2001
[New therapy developments in rheumatoid arthritis].
H. Lorenz
,
J. Kalden
Zeitschrift für Rheumatologie (Print)
2001
Corpus ID: 32775303
Despite the anti-TNF alpha based progress in the treatment of RA, it is necessary to further optimize study designs and reports…
Expand
Review
2000
Review
2000
Update on D2E7: a fully human anti-tumour necrosis factor alpha monoclonal antibody.
Joachim Kempeni
Annals of the Rheumatic Diseases
2000
Corpus ID: 30247912
Rheumatoid arthritis (RA) is characterised by persistent joint inflammation and concomitant joint destruction, and in severe…
Expand
1997
1997
THE GENERATION AND CHARACTERIZATION OF D2E7: A FULLY HUMAN ANTI‐TNF ANTIBODY: 299
D. Tracey
1997
Corpus ID: 75308473
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE